These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6141519)

  • 1. Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans.
    Bratusch-Marrain PR; Waldhäusl WK; Gasić S; Hofer A
    Metabolism; 1984 Feb; 33(2):151-7. PubMed ID: 6141519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct assessment of splanchnic uptake and metabolic effects of human and porcine insulin.
    Saccà L; Orofino G; Petrone A; Vigorito C
    J Clin Endocrinol Metab; 1984 Aug; 59(2):191-6. PubMed ID: 6145721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects.
    Waldhäusl WK; Gasić S; Bratusch-Marrain P; Korn A; Nowotny P
    Am J Physiol; 1982 Dec; 243(6):E476-82. PubMed ID: 6756164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by proinsulin of endogenous C-peptide release in healthy man.
    Waldhäusl WK; Bratusch-Marrain P; Gasić S; Komjati M; Heding L
    Am J Physiol; 1986 Aug; 251(2 Pt 1):E139-45. PubMed ID: 3526918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans.
    Meier JJ; Veldhuis JD; Butler PC
    Diabetes; 2005 Jun; 54(6):1649-56. PubMed ID: 15919785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of somatostatin on insulin and glucose levels during insulin infusion in anesthetized dogs.
    O'Brien DW; Molnar GD; Petersen TD; Rajotte RV
    Pancreas; 1990 Nov; 5(6):652-7. PubMed ID: 1980734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and splanchnic exchange of human biosynthetic C-peptide in type 1 (insulin-dependent) diabetes mellitus.
    Sjöberg S; Johansson BL; Ostman J; Wahren J
    Diabetologia; 1991 Jun; 34(6):423-8. PubMed ID: 1884901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.
    Saccà L; Cicala M; Trimarco B; Ungaro B; Vigorito C
    J Clin Invest; 1982 Jul; 70(1):117-26. PubMed ID: 6123524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of biosynthetic human proinsulin on carbohydrate metabolism.
    Revers RR; Henry R; Schmeiser L; Kolterman O; Cohen R; Bergenstal R; Polonsky K; Jaspan J; Rubenstein A; Frank B
    Diabetes; 1984 Aug; 33(8):762-70. PubMed ID: 6378699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin infusion enhances hepatic glucose production during hyperglucagonemia.
    Meneilly GS; Minaker KL; Elahi D; Rowe JW
    Metabolism; 1988 Mar; 37(3):252-6. PubMed ID: 2893970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of C-peptide:insulin molar ratio as a measure of hepatic removal of insulin.
    Berzins R; Wieczorek KR; Rajotte RV; Molnar GD; Tam YK; McGregor JR; Fawcett DM
    Diabetes Res Clin Pract; 1987 Nov; 4(1):37-43. PubMed ID: 2891470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans.
    Luzi L; DeFronzo RA
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E241-6. PubMed ID: 2669517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin impairs clearance of exogenous insulin in humans.
    Ipp E; Sinai Y; Bar-Oz B; Nesher R; Cerasi E
    Diabetes; 1987 May; 36(5):673-7. PubMed ID: 2883058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.
    Polonsky K; Jaspan J; Pugh W; Cohen D; Schneider M; Schwartz T; Moossa AR; Tager H; Rubenstein AH
    J Clin Invest; 1983 Sep; 72(3):1114-23. PubMed ID: 6350363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of C-peptide concentrations and responses to somatostatin, glucose infusion, and insulin resistance in horses.
    Tóth F; Frank N; Martin-Jiménez T; Elliott SB; Geor RJ; Boston RC
    Equine Vet J; 2010 Mar; 42(2):149-55. PubMed ID: 20156251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
    Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
    Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans.
    Shah P; Vella A; Basu A; Basu R; Adkins A; Schwenk WF; Johnson CM; Nair KS; Jensen MD; Rizza RA
    Diabetes; 2002 Feb; 51(2):301-10. PubMed ID: 11812736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.
    Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk WF; Rizza RA
    Diabetologia; 2001 Jun; 44(6):729-37. PubMed ID: 11440366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.